CClinicalTrials.gg
CompletedNCT04757324BSES-SFUpdated Feb 17, 2021

Breast Milk and Breastfeeding Education Given in the Antenatal Period

An interventional study of breastfeeding education in Breastfeeding, sponsored by Uludag University. Completed. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-17.

Sponsored by Uludag University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 4 years 1 month after the study started (first participant enrolled Jan 2017, registered Feb 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
67
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

We aimed to examine the influence of breast milk and breastfeeding education given in the ante-natal period on LATCH score and breastfeeding self-efficacy score.

Read the detailed description

Practices for increasing breastfeeding self-efficacy are of vital importance and they increase the level of breastfeeding self-efficacy. Breast milk and breastfeeding educations have given in the ante-natal period are another way of increasing the success of breastfeeding.

In this experimental investigation, 80 pregnant women who attended a baby-friendly hospital were randomly assigned to the education (n = 40) or control (n = 40) groups. The pregnant women in the intervention group received 4 hours of human milk and breastfeeding educational sessions along with routine care and furthermore, a brochure prepared by the researcher was given. All women whose estimated delivery date had approximated were questioned about whether they had given birth or not, and the sociodemographic data form, the LATCH Breastfeeding Assessment Tool and the Breastfeeding Self-efficacy Scale-short form were applied to the subjects in the education and the control group by visiting them at home when the post-partum first week had been completed.

02

Conditions studied

  • Breastfeeding

Keywords

  • Breastfeeding success
  • Breastfeeding education
  • Breastfeeding self-efficacy perception
  • Breast milk
  • Antenatal period
03

In context

Lead sponsor

Uludag University is the lead sponsor of 141 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

inclusion criteria Being above 18 years of age, Having completed the 26th gestational week (At training phase), Having no problem with vision and hearing, Having no disease that can prevent breastfeeding, Having a pregnancy with no risk, Having no systemic disease, Planning to breastfeed after birth

excusion criteria the mother stops researching. treating the baby in neonatal intensive care

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
67 participants (actual)

Study arms

  • Experimental
    education arm

    Breastfeeding training was given to the training arm

    Other: breastfeeding education

  • No intervention
    control arm

    Breastfeeding training not given to control arm

Interventions

  • Otherbreastfeeding education

    Also known as: antenatal education

06

What researchers measure

Primary outcomes

  1. Change from baseline in self-efficacy on the 70 points Breastfeeding Self-efficacy Scale-short form at week 1

    Time frame: baseline and week 1

  2. Change from baseline in LATCH score on the 70 points LATCH Breastfeeding Assessment Toolform at week 1

    breastfeeding success

    Time frame: baseline in week 1

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Ozturk R, Ergun S, Ozyazicioglu N. Effect of antenatal educational intervention on maternal breastfeeding self-efficacy and breastfeeding success: a quasi-experimental study. Rev Esc Enferm USP. 2022 Apr 4;56:e20210428. doi: 10.1590/1980-220X-REEUSP-2021-0428. eCollection 2022. PubMed 35377385 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04757324
Lead sponsor
Uludag University
Collaborators
Balikesir University
Responsible party
Rukiye Öztürk (M.Sc., Uludag University) — Principal investigator
First posted
Feb 17, 2021
Start date
Jan 1, 2017
Primary completion
Jun 1, 2017
Completion
Jan 1, 2018
Last update
Feb 17, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion